VitroScan

biotech · Leiden, NL

Chemotherapy response prediction for ovarian cancer patients.

Funding history

Date	Round	Amount
Dec 2024	Grant Leiden-based VitroScan received EUR 1.9M from the National Growth Fund's Biotech Booster to develop ovarian-cancer chemotherapy response prediction.	$2M